Industry Developments
Recent developments in the Japan Medical Device Second Opinion Market indicate a growing emphasis on advanced imaging and diagnostic technologies. Companies such as Siemens Healthineers and GE Healthcare continue to innovate, enhancing their offerings in medical imaging to support second opinions in critical healthcare decisions. In September 2023, Fujifilm announced a partnership with Terumo aimed at integrating their diagnostic tools to improve patient outcomes and streamline second opinions across medical facilities in Japan. Additionally, Olympus is advancing its endoscope technology to facilitate easier second-opinion consultations for gastrointestinal issues. In terms of market dynamics, Roche Diagnostics noted a significant increase in demand for second opinion services due to rising awareness about patient-centered care. Mergers within the sector include Canon Medical Systems acquiring certain assets of a smaller diagnostics firm in May 2023 to bolster its portfolio. This activity reflects ongoing consolidation in the market, with companies like Mitsubishi Electric and Hitachi Medical Systems actively looking for strategic partnerships to broaden their technological capabilities. Overall, these developments position Japan’s medical device sector for robust growth as advanced diagnostics become integral to healthcare delivery.
Report Scope
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 0.18(USD Billion) |
| MARKET SIZE 2024 | 0.21(USD Billion) |
| MARKET SIZE 2035 | 0.92(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 14.31% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Siemens Healthineers, Terumo, Philips Healthcare, Canon Medical Systems, SHIMADZU, Fujifilm, Roche Diagnostics, GE Healthcare, Hitachi Medical Systems, Nipro, Asahi Kasei Medical, Mitsubishi Electric, Olympus, Mizuho Medical |
| SEGMENTS COVERED | Application Outlook, Source of Service Outlook, Services Outlook, Type Outlook |
| KEY MARKET OPPORTUNITIES | Telemedicine integration, Growing aging population, Rising chronic diseases, Increased healthcare spending, Demand for personalized care |
| KEY MARKET DYNAMICS | increasing patient awareness, technological advancements, regulatory challenges, competitive landscape, rising healthcare costs |
| COUNTRIES COVERED | Japan |
FAQs
What is the expected market size of the Japan Medical Device Second Opinion Market in 2024?
The market is expected to be valued at 0.21 USD Billion in 2024.
What is the forecasted market size for the Japan Medical Device Second Opinion Market by 2035?
The expected market size for 2035 is 0.92 USD Billion.
What is the projected CAGR for the Japan Medical Device Second Opinion Market from 2025 to 2035?
The market is anticipated to grow at a CAGR of 14.31% from 2025 to 2035.
Which application segment is expected to hold the largest market share in 2035?
The Cancer application segment is projected to be valued at 0.20 USD Billion in 2035.
What are the key players in the Japan Medical Device Second Opinion Market?
Major players include Siemens Healthineers, Terumo, Philips Healthcare, and GE Healthcare.
How much is the Diabetes application segment expected to be valued in 2035?
The Diabetes application segment is projected to reach 0.16 USD Billion in 2035.
What is the expected market value for Cardiac Disorders in 2024?
The market value for Cardiac Disorders is anticipated to be 0.06 USD Billion in 2024.
What growth opportunities exist in the Japan Medical Device Second Opinion Market?
The market presents opportunities driven by technological advancements and rising healthcare demands.
What is the anticipated market value for Neurological Disorders in 2035?
The Neurological Disorders segment is projected to be valued at 0.12 USD Billion in 2035.
How will the Respiratory Disorders segment perform from 2024 to 2035?
The Respiratory Disorders segment is expected to grow from 0.03 USD Billion in 2024 to 0.20 USD Billion in 2035.
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
“Thank you, this will be very helpful for OQS.”
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Leave a Comment